API Solutions

Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner for pharma companies in more than 100 countries.

R&D

Dr. Reddy’s supplies generic APIs to 80+ countries, excelling in R\&D across niche molecules and key therapies, with capabilities from lab to production in contained/non-contained APIs and advanced chemical processes.

White Paper

Dr. Reddy’s offers insightful whitepapers sharing expertise on APIs, formulations, regulatory trends, and industry innovations, helping global pharma partners gain knowledge, solve challenges, and drive faster, compliant product development.

Dr. Reddys API Team at DCAT 2026

Dr. Reddy’s API team participated in DCAT 2026, engaging with global pharmaceutical customers and partners at one of the industry’s most important forums for business development and strategic collaboration.

During the event, the team held discussions around APIs, complex chemistries, supply reliability, and long‑term partnerships, reflecting the evolving expectations of global pharma companies. DCAT 2026 provided an opportunity to strengthen existing relationships and explore new opportunities across regulated and emerging markets. Participation at DCAT 2026 reaffirmed Dr. Reddy’s commitment to being a reliable, quality‑driven API partner, supporting customers with scalable and compliant solutions across the pharmaceutical value chain.

View More News